Wegovy Pay Monthly — What the Pricing Reality Looks Like

The myth: a low monthly headline price means low total cost

The biggest misconception around Wegovy's monthly cost is that the number shown on a provider's homepage is the number you'll pay. Frequently it isn't. Consultation fees, prescription charges and delivery costs are routinely listed separately, or buried in the checkout. Some services charge for clinical reviews each time you need a dose increase. Others add a joining fee. A few operate on a subscription model that continues charging until you remember to cancel.

When you add those layers up, the monthly figure can look quite different from the one that caught your eye. The practical habit worth building: before entering your card details anywhere, scroll to the checkout page and look for a line-items summary. If the total there differs from the advertised price and there's no explanation of why, that's useful information.

Wegovy is a prescription-only medicine, which means every dispensing must sit behind a proper clinical assessment. The full picture on Wegovy in the UK explains the licensing background, the short version is that any provider offering it without a documented clinical review is operating outside the rules, and any price that seems to reflect that omission should be treated with caution rather than enthusiasm.

What the UK private market actually charges per month

UK private pricing for Wegovy has shifted since Eli Lilly's price increase on Mounjaro in September 2025 reshaped how the whole GLP-1 market was perceived, though Wegovy is made by Novo Nordisk, not Lilly, the market moved together. Reported private prices across providers have typically ranged from roughly £149 to £375 per month depending on dose and provider, based on widely reported figures from that period. Those are hedged figures, not guarantees of what you'll find today.

What drives the variation is partly dose (lower starter doses cost less per pen, higher maintenance doses cost more) and partly what the provider wraps around the medicine. NICE's guidance on semaglutide (TA875, published March 2023) recommends it only within a specialist weight management service involving multidisciplinary care; private providers operate outside that framework, so the quality of clinical support varies significantly. Dose titration is gradual by design: the monthly dosage schedule starts low and steps up over several months, and if you're wondering whether Wegovy is taken weekly or monthly, that detail shapes how the titration and cost structure work in practice.

The NHS route exists but comes with long waiting lists and eligibility criteria that most adults in England won't currently meet. For those who don't qualify or don't want to wait, private treatment through a GPhC-registered pharmacy is the regulated alternative, and the quality of that service matters as much as the cost.

What nume charges, and why we're not trying to win on price

We're not the cheapest provider, and that's a deliberate position. One transparent price at nume covers the consultation, the prescription, the treatment itself, and free next-working-day delivery. There are no subscription fees, no auto-renewals, and no surprise charges at checkout. Every repeat order is clinically re-reviewed before we dispense, your prescriber doesn't just rubber-stamp a previous decision, they look again. Our approach to clinical oversight is built around that principle.

The honesty is straightforward: if you're choosing a provider purely on the lowest advertised number, you won't choose us. We're fine with that. What we offer instead is a GPhC-registered pharmacy (registration 9012878, verifiable on the GPhC register), a named GPhC-registered Independent Prescriber reading your consultation the same day it arrives, and a supply chain that runs through authorised Novo Nordisk channels. Semaglutide's monthly cost in broader context shows why those things have a price attached to them.

Current treatment pricing is shown on our weight loss treatments page, we don't print per-pen prices in body copy, because what you'll pay depends on the clinical assessment first.

For a prescription medicine, lowest monthly price is the wrong question

The MHRA has been explicit about the risks of sourcing GLP-1 medicines through unverified routes. Fake semaglutide pens have been seized in the UK in large quantities; some contained insulin rather than semaglutide, with serious consequences for people who used them. A seller offering Wegovy at a price that seems to undercut the legitimate market by a wide margin isn't passing on a bargain, they're removing the clinical infrastructure that makes the medicine safe to use. The MHRA's Yellow Card scheme allows you to report suspected counterfeit or unlicensed medicine sellers directly.

Paying monthly for Wegovy should mean paying for a real prescriber's time, a genuine supply chain, and aftercare you can actually reach when a question comes up. How much weight people lose on treatment varies, the monthly weight-loss data from trials gives a realistic picture, and the STEP 1 trial published in the New England Journal of Medicine reported around 15% average reduction over 68 weeks at 2.4mg. Results like those require the medicine to be genuine, dosed correctly under supervision, and supported by proper aftercare.

If you'd like a prescriber to assess whether Wegovy is suitable for you, you can speak to our prescribers through a free consultation. No obligation, no automatic charge, just a clinical review, the same day, by a real person.